2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
BayCom Corp's Board declared a quarterly cash dividend of $0.30 per share on its common stock, announced in a press release dated August 19, 2026. Shareholders of record at the close of business on September 10, 2026 will receive the payment on October 8, 2026.
Quarterly cash dividend of $0.30 per common share declared
Nordson reported record fiscal third-quarter 2026 sales of $818 million, up 10% year over year, and diluted EPS of $2.73, up 23%. The company raised its full-year guidance for sales and adjusted earnings, citing backlog up 35% over the prior year.
Q3 net income was $153 million, or $2.73 per diluted share, versus $126 million, or $2.22, a year earlier
Q3 adjusted EPS was a record $3.25, up 19%, excluding a non-cash loss on a minority investment and acquisition-related items
Full-year sales guidance now $3,035 million to $3,075 million; adjusted EPS guidance now $11.80 to $12.00
Management will discuss results on a webcast on August 20, 2026 at 8:30 a.m. Eastern
Peoples Financial Services Corp. (PFIS) furnished a 2026 Q2 investor presentation as Exhibit 99.1 to an 8-K, for use in investor meetings during 2026. The presentation reports Q2 2026 net income of $14.8 million, or $1.48 per diluted share, compared with $1.47 in Q1 2026, and tangible book value per share of $43.51, up $1.22 from the prior quarter.
Q2 2026 net income of $14.8 million, or $1.48 per diluted share, versus $1.47 in Q1 2026
ROATCE of 13.7%, net interest margin (FTE) of 3.82%, and efficiency ratio of 55.2% for Q2 2026
Nonperforming loans to total loans rose to 0.33% at June 30, 2026, from 0.28% at March 31, 2026
Tangible book value per share of $43.51 at June 30, 2026, up $1.22 quarter over quarter
Aurinia Pharmaceuticals said it has settled patent infringement litigation with Teva Pharmaceuticals over Teva's application to sell a generic 7.9 mg voclosporin capsule in the United States. Under the settlement, Teva has stipulated that Aurinia's two U.S. patents are enforceable, valid and would be infringed, and Teva may launch no earlier than December 7, 2036, subject to earlier contingencies and FDA approval. The filing gives no financial figures, and Aurinia's other patent actions continue.
Teva stipulated that U.S. Patent Nos. 10,286,036 and 11,622,991 are enforceable, valid and would be infringed, and that the patents expire in December 2037.
Teva may launch its generic voclosporin no earlier than December 7, 2036, unless defined contingencies occur earlier.
Teva's U.S. launch also depends on FDA approval of its generic product.
Aurinia's patent infringement actions against five other companies continue in the U.S. District Court for the District of New Jersey.
TJX reported second-quarter fiscal 2027 net sales of $15.2 billion, up 5%, with comparable sales up 4% and diluted earnings per share of $1.36, up 24% from $1.10. The company raised its full-year fiscal 2027 pretax profit margin and diluted EPS outlook, to $5.31 to $5.36 per share. Q2 results include a net benefit from IEEPA tariff refunds, so adjusted diluted EPS was $1.22, up 11%.
Q2 net sales $15.2 billion, up 5%; comparable sales up 4%, with Marmaxx at +1% and HomeGoods at +7%
Q2 diluted EPS $1.36 vs. $1.10 a year earlier; adjusted diluted EPS $1.22 excluding a $.14 net tariff refund benefit
Full-year fiscal 2027 diluted EPS outlook raised to $5.31 to $5.36; adjusted outlook $5.15 to $5.20
Returned $1.3 billion to shareholders in Q2 through buybacks ($798 million) and dividends ($529 million)
Estée Lauder reported fiscal 2026 results for the year ended June 30, 2026, with net sales up 5% to $15.0 billion and diluted earnings of $0.50 per share, compared with a loss of $3.15 per share a year earlier, which included large impairment charges. The company affirmed its fiscal 2027 organic net sales growth outlook of 3% to 5% and raised its adjusted operating margin outlook to 12.7% to 13.5%.
Full-year net sales were $15.0 billion, up 5% as reported and up 3% organically.
Diluted earnings were $0.50 per share, versus a loss of $3.15 per share in fiscal 2025; adjusted diluted earnings were $2.51, up from $1.51.
Fiscal 2027 outlook: organic net sales growth of 3% to 5% affirmed; adjusted operating margin outlook raised to 12.7% to 13.5%.
Free cash flow was $1.32 billion, compared with $0.67 billion in the prior year.
Target reported second-quarter 2026 net sales of $26.5 billion, up 5.3 percent, and diluted EPS of $4.11 versus $2.05 a year earlier. The results include a $994 million tariff refund benefit worth $1.65 per share, and excluding refunds EPS rose 20 percent. Target raised its full-year 2026 net sales growth outlook to around 5 percent and set a full-year EPS range of $9.90 to $10.90, which includes the refund benefit.
Q2 net sales of $26.5 billion rose 5.3 percent; comparable sales grew 3.8 percent, with digital comparable sales up 8.7 percent.
Q2 operating income was $2.6 billion versus $1.3 billion last year, including the $994 million tariff refund benefit.
Full-year 2026 EPS guidance is $9.90 to $10.90, including about $1.65 of Q2 tariff refund benefit; the company excludes potential future refunds from guidance.
No stock was repurchased in Q2; about $8.3 billion remained under the repurchase program approved in August 2021.
Stock Yards Bancorp's Board of Directors voted on August 18, 2026, to increase the quarterly cash dividend to $0.33 per common share, payable October 1, 2026, to holders of record as of September 21, 2026. The company says it has raised its dividend 19 times since 2011, a cumulative increase of 175%, which gives shareholders a higher cash payout per share each quarter.
Quarterly cash dividend increased to $0.33 per common share
Payable October 1, 2026, to stockholders of record as of September 21, 2026
Board approved the increase on August 18, 2026; press release issued August 19, 2026
CEO James A. Hillebrand said the company has raised its quarterly dividend 19 times since 2011, a cumulative increase of 175%
Analog Devices reported fiscal third-quarter 2026 revenue of $4.02 billion for the quarter ended August 1, 2026, up 40% from $2.88 billion a year earlier, and diluted earnings per share of $2.74 versus $1.04. The company forecast fourth-quarter revenue of $4.3 billion, plus or minus $100 million, and reported EPS of $3.14, plus or minus $0.15, and it declared a $1.10 quarterly dividend.
Q3 revenue $4.02 billion, up 40% from $2.88 billion; operating income $1.61 billion versus $818 million
Diluted EPS $2.74 versus $1.04; adjusted diluted EPS $3.45 versus $2.05
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.